Dietary Antioxidants and the Mitochondrial Quality Control: Their Potential Roles in Parkinson’s Disease Treatment

Dietary Antioxidants and the Mitochondrial Quality Control: Their Potential Roles in Parkinson’s Disease Treatment

Advances in medicine and dietary standards over recent decades have remarkably increased human life expectancy. Unfortunately, the chance of developing age-related diseases, including neurodegenerative diseases (NDDs), increases with increased life expectancy. High metabolic demands of neurons are m...

Full description

Bibliographic Details
Main Authors:	Davin Lee, Min Gu Jo, Seung Yeon Kim, Chang Geon Chung, Sung Bae Lee
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Antioxidants
Subjects:	dietary antioxidants mitochondria reactive oxygen species neurodegenerative disease Parkinson’s disease mitochondrial quality control
Online Access:	https://www.mdpi.com/2076-3921/9/11/1056

Similar Items

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
by: Alexander Blagov, et al.
Published: (2024-01-01)

Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases
by: Sydney Bartman, et al.
Published: (2024-03-01)

Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease: The Emerging Role of VDAC
by: Pierpaolo Risiglione, et al.
Published: (2021-05-01)

Effect of Chronic Stress Present in Fibroblasts Derived from Patients with a Sporadic Form of AD on Mitochondrial Function and Mitochondrial Turnover
by: Karolina Drabik, et al.
Published: (2021-06-01)

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA
by: Olga Buneeva, et al.
Published: (2020-12-01)

Exploring the role of Prx II in mitigating endoplasmic reticulum stress and mitochondrial dysfunction in neurodegeneration
by: Mei-Hua Jin, et al.
Published: (2024-04-01)

Hyperbaric Oxygen Therapy Improves Parkinson’s Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway
by: Hung-Te Hsu, et al.
Published: (2022-04-01)

Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson’s Disease Models by Alleviating Oxidative Stress
by: Yue Wu, et al.
Published: (2023-01-01)

Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases
by: Luis F. González, et al.
Published: (2021-12-01)

Mitochondrial Calcium: Effects of Its Imbalance in Disease
by: Deyamira Matuz-Mares, et al.
Published: (2022-04-01)

Potential Applications of Mitochondrial Therapy with a Focus on Parkinson’s Disease and Mitochondrial Transplantation
by: Pranay Wal, et al.
Published: (2024-03-01)

Type 2 diabetes mellitus and neurodegenerative disorders: The mitochondrial connection
by: Isabella R. Baduini, et al.
Published: (2024-11-01)

PET Imaging for Oxidative Stress in Neurodegenerative Disorders Associated with Mitochondrial Dysfunction
by: Masamichi Ikawa, et al.
Published: (2020-09-01)

Dietary Iron Overload and <i>Hfe<sup>−/−</sup></i> Related Hemochromatosis Alter Hepatic Mitochondrial Function
by: Christine Fischer, et al.
Published: (2021-11-01)

Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson's disease
by: Hyeyoon Eo, et al.
Published: (2024-07-01)

The importance of using methods of selective modification of neuronal function in the pathogenesis and therapy of Parkinson's disease
by: Maciej Superson, et al.
Published: (2024-07-01)

PET Imaging with [<sup>18</sup>F]ROStrace Detects Oxidative Stress and Predicts Parkinson’s Disease Progression in Mice
by: Yi Zhu, et al.
Published: (2024-10-01)

Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids
by: Tae Yeon Kim, et al.
Published: (2020-07-01)

Targeting Mitochondrial Function with Chemoptogenetics
by: Amy Romesberg, et al.
Published: (2022-10-01)

Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal models of Parkinson’s disease
by: Muhammet Ay, et al.
Published: (2024-02-01)

Mitochondrial dysfunction and Parkinson’s disease — near-infrared photobiomodulation as a potential therapeutic strategy
by: Foo, Aaron Song Chuan, et al.
Published: (2021)

The Cyclic Nitroxide TEMPOL Ameliorates Oxidative Stress but Not Inflammation in a Cell Model of Parkinson’s Disease
by: Alexander Leathem, et al.
Published: (2022-01-01)

A Mitochondrial Perspective on Noncommunicable Diseases
by: Yifan Zheng, et al.
Published: (2023-02-01)

Oxidative Stress in the Pathogenesis of Neurodegenerative Diseases
by: Maria-Carolina Jurcau, et al.
Published: (2024-12-01)

Predicting Mitochondrial Dynamic Behavior in Genetically Defined Neurodegenerative Diseases
by: Gerald W. Dorn, et al.
Published: (2022-03-01)

Role of Mitochondrial Protein Import in Age-Related Neurodegenerative and Cardiovascular Diseases
by: Andrey Bogorodskiy, et al.
Published: (2021-12-01)

Mitochondrial Alterations, Oxidative Stress, and Therapeutic Implications in Alzheimer’s Disease: A Narrative Review
by: Erica Spina, et al.
Published: (2025-02-01)

Mitochondrial Phenotypes in Genetically Diverse Neurodegenerative Diseases and Their Response to Mitofusin Activation
by: Xiawei Dang, et al.
Published: (2022-03-01)

Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson’s Disease
by: Heng-Chung Kung, et al.
Published: (2021-07-01)

Mitochondrial Dysfunction in Neurodegenerative Diseases
by: Han-Mo Yang
Published: (2025-02-01)

Mitochondrial Neurodegenerative Diseases: Three Mitochondrial Ribosomal Proteins as Intermediate Stage in the Pathway That Associates Damaged Genes with Alzheimer’s and Parkinson’s
by: Luigi Del Giudice, et al.
Published: (2023-07-01)

No association between adult height and Parkinson's disease
by: Younggee Jeong, et al.
Published: (2023-01-01)

Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease
by: Alexander V. Blagov, et al.
Published: (2022-11-01)

Parkinson's Disease and Mitotherapy-Based Approaches towards α-Synucleinopathies
by: Vidhi Bhatt, et al.
Published: (2024-05-01)

Effects of Treadmill Exercise on Neural Mitochondrial Functions in Parkinson’s Disease: A Systematic Review of Animal Studies
by: Nguyen Thanh Nhu, et al.
Published: (2021-08-01)

GPX3 as a Novel and Potential Therapeutic Target in the Shared Molecular Mechanisms of Traumatic Brain Injury and Parkinson’s Disease
by: Wang Y, et al.
Published: (2025-02-01)

The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease
by: Xiaoyang Huang, et al.
Published: (2022-12-01)

Impact of Glucocorticoid on a Cellular Model of Parkinson’s Disease: Oxidative Stress and Mitochondrial Function
by: Silvia Claros, et al.
Published: (2021-08-01)

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
by: Srinivasa Reddy Bonam, et al.
Published: (2021-12-01)

Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
by: Francisca Villavicencio Tejo, et al.
Published: (2021-07-01)